Share Purchase Options (Details) |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Nov. 08, 2018
$ / shares
|
Dec. 31, 2018
$ / shares
shares
|
Aug. 31, 2018
$ / shares
shares
|
May 31, 2019
shares
|
|
Share-based Payment Arrangement [Abstract] | ||||
Percentage of stock option | 20.00% | |||
Issuance of common stock for additional, shares | 17,969,849 | |||
Granted share options to directors | 9,775,000 | |||
Fair value of the warrants granted (in Dollars per share) | $ / shares | $ 0.42 | $ 0.87 | ||
Common stock shares | 50,000 | |||
Exercise price (in Dollars per share) | $ / shares | $ 4.80 |
X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fixed interest rate related to the interest rate derivative. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|